nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Myocardial infarction—Imiquimod—skin cancer	0.00487	0.00488	CcSEcCtD
Esmolol—Neuropathy peripheral—Imiquimod—skin cancer	0.00487	0.00488	CcSEcCtD
Esmolol—Cardiac disorder—Vemurafenib—skin cancer	0.00486	0.00486	CcSEcCtD
Esmolol—Angiopathy—Vemurafenib—skin cancer	0.00475	0.00475	CcSEcCtD
Esmolol—Chills—Vemurafenib—skin cancer	0.0047	0.0047	CcSEcCtD
Esmolol—Abnormal vision—Temozolomide—skin cancer	0.00465	0.00465	CcSEcCtD
Esmolol—Pleural effusion—Docetaxel—skin cancer	0.00463	0.00463	CcSEcCtD
Esmolol—Mental disability—Temozolomide—skin cancer	0.00462	0.00462	CcSEcCtD
Esmolol—Erythema—Vemurafenib—skin cancer	0.00456	0.00456	CcSEcCtD
Esmolol—Rhinitis—Imiquimod—skin cancer	0.00447	0.00448	CcSEcCtD
Esmolol—Thrombophlebitis—Temozolomide—skin cancer	0.00447	0.00447	CcSEcCtD
Esmolol—Dysgeusia—Vemurafenib—skin cancer	0.00446	0.00446	CcSEcCtD
Esmolol—Pharyngitis—Imiquimod—skin cancer	0.00443	0.00443	CcSEcCtD
Esmolol—Urinary tract disorder—Imiquimod—skin cancer	0.00441	0.00441	CcSEcCtD
Esmolol—Myocardial ischaemia—Docetaxel—skin cancer	0.00441	0.00441	CcSEcCtD
Esmolol—Urethral disorder—Imiquimod—skin cancer	0.00438	0.00438	CcSEcCtD
Esmolol—Rigors—Docetaxel—skin cancer	0.00434	0.00434	CcSEcCtD
Esmolol—Asthenia—Vismodegib—skin cancer	0.00432	0.00432	CcSEcCtD
Esmolol—Visual impairment—Imiquimod—skin cancer	0.0043	0.0043	CcSEcCtD
Esmolol—Pruritus—Vismodegib—skin cancer	0.00426	0.00426	CcSEcCtD
Esmolol—Nasal congestion—Temozolomide—skin cancer	0.00424	0.00425	CcSEcCtD
Esmolol—Flushing—Imiquimod—skin cancer	0.00414	0.00414	CcSEcCtD
Esmolol—Thrombophlebitis—Fluorouracil—skin cancer	0.00412	0.00412	CcSEcCtD
Esmolol—Extravasation—Docetaxel—skin cancer	0.00406	0.00406	CcSEcCtD
Esmolol—Angiopathy—Imiquimod—skin cancer	0.00405	0.00405	CcSEcCtD
Esmolol—Chills—Imiquimod—skin cancer	0.00401	0.00401	CcSEcCtD
Esmolol—Mental disorder—Imiquimod—skin cancer	0.00391	0.00391	CcSEcCtD
Esmolol—Bronchospasm—Bleomycin—skin cancer	0.0039	0.0039	CcSEcCtD
Esmolol—Erythema—Imiquimod—skin cancer	0.00389	0.00389	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00385	0.00385	CcSEcCtD
Esmolol—Oliguria—Docetaxel—skin cancer	0.00384	0.00385	CcSEcCtD
Esmolol—Vomiting—Vismodegib—skin cancer	0.00383	0.00383	CcSEcCtD
Esmolol—Dermatitis bullous—Fluorouracil—skin cancer	0.00373	0.00373	CcSEcCtD
Esmolol—Inflammation—Docetaxel—skin cancer	0.00365	0.00365	CcSEcCtD
Esmolol—Cardiac failure—Fluorouracil—skin cancer	0.00365	0.00365	CcSEcCtD
Esmolol—Nervous system disorder—Vemurafenib—skin cancer	0.00365	0.00365	CcSEcCtD
Esmolol—Skin disorder—Vemurafenib—skin cancer	0.00361	0.00361	CcSEcCtD
Esmolol—Respiratory failure—Docetaxel—skin cancer	0.00361	0.00361	CcSEcCtD
Esmolol—Nausea—Vismodegib—skin cancer	0.00358	0.00358	CcSEcCtD
Esmolol—Agitation—Imiquimod—skin cancer	0.00357	0.00357	CcSEcCtD
Esmolol—Angioedema—Imiquimod—skin cancer	0.00355	0.00355	CcSEcCtD
Esmolol—Syncope—Imiquimod—skin cancer	0.00348	0.00349	CcSEcCtD
Esmolol—Acute coronary syndrome—Bleomycin—skin cancer	0.00348	0.00348	CcSEcCtD
Esmolol—Hypotension—Vemurafenib—skin cancer	0.00347	0.00348	CcSEcCtD
Esmolol—Myocardial infarction—Bleomycin—skin cancer	0.00346	0.00346	CcSEcCtD
Esmolol—Loss of consciousness—Imiquimod—skin cancer	0.00342	0.00342	CcSEcCtD
Esmolol—Irritability—Fluorouracil—skin cancer	0.0034	0.0034	CcSEcCtD
Esmolol—Cardiac arrest—Fluorouracil—skin cancer	0.00339	0.00339	CcSEcCtD
Esmolol—Skin exfoliation—Docetaxel—skin cancer	0.00338	0.00338	CcSEcCtD
Esmolol—Convulsion—Imiquimod—skin cancer	0.00337	0.00337	CcSEcCtD
Esmolol—Neuropathy—Docetaxel—skin cancer	0.00333	0.00333	CcSEcCtD
Esmolol—Chest pain—Imiquimod—skin cancer	0.00331	0.00331	CcSEcCtD
Esmolol—Anxiety—Imiquimod—skin cancer	0.0033	0.0033	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00329	0.00329	CcSEcCtD
Esmolol—Sweating increased—Temozolomide—skin cancer	0.00326	0.00326	CcSEcCtD
Esmolol—Dry mouth—Imiquimod—skin cancer	0.00324	0.00324	CcSEcCtD
Esmolol—Decreased appetite—Vemurafenib—skin cancer	0.00323	0.00323	CcSEcCtD
Esmolol—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00321	0.00321	CcSEcCtD
Esmolol—Fatigue—Vemurafenib—skin cancer	0.00321	0.00321	CcSEcCtD
Esmolol—Nasopharyngitis—Fluorouracil—skin cancer	0.00319	0.00319	CcSEcCtD
Esmolol—Constipation—Vemurafenib—skin cancer	0.00318	0.00318	CcSEcCtD
Esmolol—Oedema—Imiquimod—skin cancer	0.00317	0.00317	CcSEcCtD
Esmolol—Lightheadedness—Docetaxel—skin cancer	0.00317	0.00317	CcSEcCtD
Esmolol—Pulmonary oedema—Docetaxel—skin cancer	0.00315	0.00315	CcSEcCtD
Esmolol—Dysuria—Temozolomide—skin cancer	0.00313	0.00313	CcSEcCtD
Esmolol—Shock—Imiquimod—skin cancer	0.00312	0.00312	CcSEcCtD
Esmolol—Nervous system disorder—Imiquimod—skin cancer	0.00311	0.00311	CcSEcCtD
Esmolol—Skin disorder—Imiquimod—skin cancer	0.00308	0.00308	CcSEcCtD
Esmolol—Hyperhidrosis—Imiquimod—skin cancer	0.00307	0.00307	CcSEcCtD
Esmolol—Anorexia—Imiquimod—skin cancer	0.00302	0.00302	CcSEcCtD
Esmolol—Angina pectoris—Fluorouracil—skin cancer	0.003	0.003	CcSEcCtD
Esmolol—Thrombophlebitis—Docetaxel—skin cancer	0.00297	0.00297	CcSEcCtD
Esmolol—Flushing—Bleomycin—skin cancer	0.00294	0.00294	CcSEcCtD
Esmolol—Body temperature increased—Vemurafenib—skin cancer	0.00294	0.00294	CcSEcCtD
Esmolol—Pharyngitis—Dactinomycin—skin cancer	0.00294	0.00294	CcSEcCtD
Esmolol—Neuropathy peripheral—Temozolomide—skin cancer	0.00292	0.00292	CcSEcCtD
Esmolol—Paraesthesia—Imiquimod—skin cancer	0.00285	0.00285	CcSEcCtD
Esmolol—Chills—Bleomycin—skin cancer	0.00285	0.00285	CcSEcCtD
Esmolol—Cardiac failure congestive—Docetaxel—skin cancer	0.00284	0.00284	CcSEcCtD
Esmolol—Dyspnoea—Imiquimod—skin cancer	0.00283	0.00283	CcSEcCtD
Esmolol—Somnolence—Imiquimod—skin cancer	0.00282	0.00282	CcSEcCtD
Esmolol—Dyspepsia—Imiquimod—skin cancer	0.00279	0.00279	CcSEcCtD
Esmolol—Erythema—Bleomycin—skin cancer	0.00276	0.00276	CcSEcCtD
Esmolol—Decreased appetite—Imiquimod—skin cancer	0.00276	0.00276	CcSEcCtD
Esmolol—Flushing—Dactinomycin—skin cancer	0.00274	0.00275	CcSEcCtD
Esmolol—Gastrointestinal disorder—Imiquimod—skin cancer	0.00274	0.00274	CcSEcCtD
Esmolol—Fatigue—Imiquimod—skin cancer	0.00273	0.00274	CcSEcCtD
Esmolol—Pain—Imiquimod—skin cancer	0.00271	0.00271	CcSEcCtD
Esmolol—Acute coronary syndrome—Fluorouracil—skin cancer	0.00271	0.00271	CcSEcCtD
Esmolol—Neuropathy peripheral—Fluorouracil—skin cancer	0.00269	0.00269	CcSEcCtD
Esmolol—Myocardial infarction—Fluorouracil—skin cancer	0.00269	0.00269	CcSEcCtD
Esmolol—Dermatitis bullous—Docetaxel—skin cancer	0.00269	0.00269	CcSEcCtD
Esmolol—Asthenia—Vemurafenib—skin cancer	0.00267	0.00267	CcSEcCtD
Esmolol—Pharyngitis—Temozolomide—skin cancer	0.00265	0.00266	CcSEcCtD
Esmolol—Chills—Dactinomycin—skin cancer	0.00265	0.00265	CcSEcCtD
Esmolol—Urinary tract disorder—Temozolomide—skin cancer	0.00264	0.00264	CcSEcCtD
Esmolol—Cardiac failure—Docetaxel—skin cancer	0.00263	0.00264	CcSEcCtD
Esmolol—Pruritus—Vemurafenib—skin cancer	0.00263	0.00263	CcSEcCtD
Esmolol—Urethral disorder—Temozolomide—skin cancer	0.00262	0.00262	CcSEcCtD
Esmolol—Feeling abnormal—Imiquimod—skin cancer	0.00261	0.00261	CcSEcCtD
Esmolol—Visual impairment—Temozolomide—skin cancer	0.00258	0.00258	CcSEcCtD
Esmolol—Erythema—Dactinomycin—skin cancer	0.00257	0.00258	CcSEcCtD
Esmolol—Urticaria—Imiquimod—skin cancer	0.00252	0.00252	CcSEcCtD
Esmolol—Body temperature increased—Imiquimod—skin cancer	0.00251	0.00251	CcSEcCtD
Esmolol—Cardiac disorder—Temozolomide—skin cancer	0.00248	0.00248	CcSEcCtD
Esmolol—Flushing—Temozolomide—skin cancer	0.00248	0.00248	CcSEcCtD
Esmolol—Rhinitis—Fluorouracil—skin cancer	0.00247	0.00247	CcSEcCtD
Esmolol—Dizziness—Vemurafenib—skin cancer	0.00246	0.00246	CcSEcCtD
Esmolol—Pharyngitis—Fluorouracil—skin cancer	0.00245	0.00245	CcSEcCtD
Esmolol—Angiopathy—Temozolomide—skin cancer	0.00243	0.00243	CcSEcCtD
Esmolol—Chills—Temozolomide—skin cancer	0.0024	0.0024	CcSEcCtD
Esmolol—Vomiting—Vemurafenib—skin cancer	0.00236	0.00237	CcSEcCtD
Esmolol—Chest pain—Bleomycin—skin cancer	0.00235	0.00235	CcSEcCtD
Esmolol—Mental disorder—Temozolomide—skin cancer	0.00234	0.00234	CcSEcCtD
Esmolol—Headache—Vemurafenib—skin cancer	0.00233	0.00233	CcSEcCtD
Esmolol—Erythema—Temozolomide—skin cancer	0.00233	0.00233	CcSEcCtD
Esmolol—Nasopharyngitis—Docetaxel—skin cancer	0.0023	0.0023	CcSEcCtD
Esmolol—Dysgeusia—Temozolomide—skin cancer	0.00228	0.00228	CcSEcCtD
Esmolol—Asthenia—Imiquimod—skin cancer	0.00228	0.00228	CcSEcCtD
Esmolol—Confusional state—Bleomycin—skin cancer	0.00227	0.00227	CcSEcCtD
Esmolol—Oedema—Bleomycin—skin cancer	0.00225	0.00225	CcSEcCtD
Esmolol—Pruritus—Imiquimod—skin cancer	0.00224	0.00224	CcSEcCtD
Esmolol—Nausea—Vemurafenib—skin cancer	0.00221	0.00221	CcSEcCtD
Esmolol—Bronchospasm—Docetaxel—skin cancer	0.00219	0.00219	CcSEcCtD
Esmolol—Angina pectoris—Docetaxel—skin cancer	0.00216	0.00217	CcSEcCtD
Esmolol—Anorexia—Bleomycin—skin cancer	0.00215	0.00215	CcSEcCtD
Esmolol—Erythema—Fluorouracil—skin cancer	0.00215	0.00215	CcSEcCtD
Esmolol—Agitation—Temozolomide—skin cancer	0.00214	0.00214	CcSEcCtD
Esmolol—Angioedema—Temozolomide—skin cancer	0.00213	0.00213	CcSEcCtD
Esmolol—Hypotension—Bleomycin—skin cancer	0.00211	0.00211	CcSEcCtD
Esmolol—Oedema—Dactinomycin—skin cancer	0.0021	0.0021	CcSEcCtD
Esmolol—Dizziness—Imiquimod—skin cancer	0.0021	0.0021	CcSEcCtD
Esmolol—Paraesthesia—Bleomycin—skin cancer	0.00202	0.00202	CcSEcCtD
Esmolol—Convulsion—Temozolomide—skin cancer	0.00202	0.00202	CcSEcCtD
Esmolol—Vomiting—Imiquimod—skin cancer	0.00202	0.00202	CcSEcCtD
Esmolol—Dyspnoea—Bleomycin—skin cancer	0.00201	0.00201	CcSEcCtD
Esmolol—Anorexia—Dactinomycin—skin cancer	0.002	0.002	CcSEcCtD
Esmolol—Headache—Imiquimod—skin cancer	0.00199	0.00199	CcSEcCtD
Esmolol—Anxiety—Temozolomide—skin cancer	0.00198	0.00198	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00197	0.00197	CcSEcCtD
Esmolol—Decreased appetite—Bleomycin—skin cancer	0.00196	0.00196	CcSEcCtD
Esmolol—Acute coronary syndrome—Docetaxel—skin cancer	0.00195	0.00195	CcSEcCtD
Esmolol—Neuropathy peripheral—Docetaxel—skin cancer	0.00194	0.00194	CcSEcCtD
Esmolol—Myocardial infarction—Docetaxel—skin cancer	0.00194	0.00194	CcSEcCtD
Esmolol—Dry mouth—Temozolomide—skin cancer	0.00194	0.00194	CcSEcCtD
Esmolol—Pain—Bleomycin—skin cancer	0.00193	0.00193	CcSEcCtD
Esmolol—Confusional state—Temozolomide—skin cancer	0.00192	0.00192	CcSEcCtD
Esmolol—Oedema—Temozolomide—skin cancer	0.0019	0.0019	CcSEcCtD
Esmolol—Nausea—Imiquimod—skin cancer	0.00188	0.00188	CcSEcCtD
Esmolol—Nervous system disorder—Temozolomide—skin cancer	0.00186	0.00186	CcSEcCtD
Esmolol—Convulsion—Fluorouracil—skin cancer	0.00186	0.00186	CcSEcCtD
Esmolol—Feeling abnormal—Bleomycin—skin cancer	0.00186	0.00186	CcSEcCtD
Esmolol—Skin disorder—Temozolomide—skin cancer	0.00185	0.00185	CcSEcCtD
Esmolol—Hyperhidrosis—Temozolomide—skin cancer	0.00184	0.00184	CcSEcCtD
Esmolol—Chest pain—Fluorouracil—skin cancer	0.00183	0.00183	CcSEcCtD
Esmolol—Decreased appetite—Dactinomycin—skin cancer	0.00183	0.00183	CcSEcCtD
Esmolol—Fatigue—Dactinomycin—skin cancer	0.00181	0.00181	CcSEcCtD
Esmolol—Anorexia—Temozolomide—skin cancer	0.00181	0.00181	CcSEcCtD
Esmolol—Pain—Dactinomycin—skin cancer	0.0018	0.0018	CcSEcCtD
Esmolol—Urticaria—Bleomycin—skin cancer	0.00179	0.00179	CcSEcCtD
Esmolol—Rhinitis—Docetaxel—skin cancer	0.00178	0.00178	CcSEcCtD
Esmolol—Body temperature increased—Bleomycin—skin cancer	0.00178	0.00178	CcSEcCtD
Esmolol—Confusional state—Fluorouracil—skin cancer	0.00177	0.00177	CcSEcCtD
Esmolol—Pharyngitis—Docetaxel—skin cancer	0.00177	0.00177	CcSEcCtD
Esmolol—Urinary tract disorder—Docetaxel—skin cancer	0.00176	0.00176	CcSEcCtD
Esmolol—Oedema—Fluorouracil—skin cancer	0.00175	0.00175	CcSEcCtD
Esmolol—Urethral disorder—Docetaxel—skin cancer	0.00174	0.00174	CcSEcCtD
Esmolol—Feeling abnormal—Dactinomycin—skin cancer	0.00173	0.00173	CcSEcCtD
Esmolol—Nervous system disorder—Fluorouracil—skin cancer	0.00172	0.00172	CcSEcCtD
Esmolol—Visual impairment—Docetaxel—skin cancer	0.00171	0.00171	CcSEcCtD
Esmolol—Paraesthesia—Temozolomide—skin cancer	0.00171	0.00171	CcSEcCtD
Esmolol—Dyspnoea—Temozolomide—skin cancer	0.00169	0.00169	CcSEcCtD
Esmolol—Somnolence—Temozolomide—skin cancer	0.00169	0.00169	CcSEcCtD
Esmolol—Dyspepsia—Temozolomide—skin cancer	0.00167	0.00167	CcSEcCtD
Esmolol—Anorexia—Fluorouracil—skin cancer	0.00167	0.00167	CcSEcCtD
Esmolol—Body temperature increased—Dactinomycin—skin cancer	0.00166	0.00166	CcSEcCtD
Esmolol—Decreased appetite—Temozolomide—skin cancer	0.00165	0.00165	CcSEcCtD
Esmolol—Flushing—Docetaxel—skin cancer	0.00165	0.00165	CcSEcCtD
Esmolol—Cardiac disorder—Docetaxel—skin cancer	0.00165	0.00165	CcSEcCtD
Esmolol—Gastrointestinal disorder—Temozolomide—skin cancer	0.00164	0.00164	CcSEcCtD
Esmolol—Fatigue—Temozolomide—skin cancer	0.00164	0.00164	CcSEcCtD
Esmolol—Hypotension—Fluorouracil—skin cancer	0.00164	0.00164	CcSEcCtD
Esmolol—Constipation—Temozolomide—skin cancer	0.00163	0.00163	CcSEcCtD
Esmolol—Pain—Temozolomide—skin cancer	0.00163	0.00163	CcSEcCtD
Esmolol—Asthenia—Bleomycin—skin cancer	0.00162	0.00162	CcSEcCtD
Esmolol—Angiopathy—Docetaxel—skin cancer	0.00161	0.00161	CcSEcCtD
Esmolol—Chills—Docetaxel—skin cancer	0.0016	0.0016	CcSEcCtD
Esmolol—Pruritus—Bleomycin—skin cancer	0.00159	0.00159	CcSEcCtD
Esmolol—Paraesthesia—Fluorouracil—skin cancer	0.00157	0.00157	CcSEcCtD
Esmolol—Feeling abnormal—Temozolomide—skin cancer	0.00157	0.00157	CcSEcCtD
Esmolol—Dyspnoea—Fluorouracil—skin cancer	0.00156	0.00156	CcSEcCtD
Esmolol—Mental disorder—Docetaxel—skin cancer	0.00156	0.00156	CcSEcCtD
Esmolol—Somnolence—Fluorouracil—skin cancer	0.00156	0.00156	CcSEcCtD
Esmolol—Erythema—Docetaxel—skin cancer	0.00155	0.00155	CcSEcCtD
Esmolol—Dyspepsia—Fluorouracil—skin cancer	0.00154	0.00154	CcSEcCtD
Esmolol—Decreased appetite—Fluorouracil—skin cancer	0.00152	0.00152	CcSEcCtD
Esmolol—Dysgeusia—Docetaxel—skin cancer	0.00152	0.00152	CcSEcCtD
Esmolol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00151	0.00151	CcSEcCtD
Esmolol—Urticaria—Temozolomide—skin cancer	0.00151	0.00151	CcSEcCtD
Esmolol—Asthenia—Dactinomycin—skin cancer	0.00151	0.00151	CcSEcCtD
Esmolol—Body temperature increased—Temozolomide—skin cancer	0.0015	0.0015	CcSEcCtD
Esmolol—Pain—Fluorouracil—skin cancer	0.0015	0.0015	CcSEcCtD
Esmolol—Feeling abnormal—Fluorouracil—skin cancer	0.00144	0.00144	CcSEcCtD
Esmolol—Vomiting—Bleomycin—skin cancer	0.00143	0.00143	CcSEcCtD
Esmolol—Urticaria—Fluorouracil—skin cancer	0.00139	0.00139	CcSEcCtD
Esmolol—Syncope—Docetaxel—skin cancer	0.00139	0.00139	CcSEcCtD
Esmolol—Body temperature increased—Fluorouracil—skin cancer	0.00138	0.00138	CcSEcCtD
Esmolol—Asthenia—Temozolomide—skin cancer	0.00136	0.00136	CcSEcCtD
Esmolol—Loss of consciousness—Docetaxel—skin cancer	0.00136	0.00136	CcSEcCtD
Esmolol—Pruritus—Temozolomide—skin cancer	0.00134	0.00134	CcSEcCtD
Esmolol—Convulsion—Docetaxel—skin cancer	0.00134	0.00134	CcSEcCtD
Esmolol—Nausea—Bleomycin—skin cancer	0.00134	0.00134	CcSEcCtD
Esmolol—Vomiting—Dactinomycin—skin cancer	0.00134	0.00134	CcSEcCtD
Esmolol—Chest pain—Docetaxel—skin cancer	0.00132	0.00132	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00131	0.00131	CcSEcCtD
Esmolol—Dry mouth—Docetaxel—skin cancer	0.00129	0.00129	CcSEcCtD
Esmolol—Confusional state—Docetaxel—skin cancer	0.00127	0.00127	CcSEcCtD
Esmolol—Oedema—Docetaxel—skin cancer	0.00126	0.00126	CcSEcCtD
Esmolol—Dizziness—Temozolomide—skin cancer	0.00126	0.00126	CcSEcCtD
Esmolol—Nausea—Dactinomycin—skin cancer	0.00125	0.00125	CcSEcCtD
Esmolol—Shock—Docetaxel—skin cancer	0.00124	0.00124	CcSEcCtD
Esmolol—Nervous system disorder—Docetaxel—skin cancer	0.00124	0.00124	CcSEcCtD
Esmolol—Pruritus—Fluorouracil—skin cancer	0.00124	0.00124	CcSEcCtD
Esmolol—Skin disorder—Docetaxel—skin cancer	0.00123	0.00123	CcSEcCtD
Esmolol—Vomiting—Temozolomide—skin cancer	0.00121	0.00121	CcSEcCtD
Esmolol—Anorexia—Docetaxel—skin cancer	0.0012	0.00121	CcSEcCtD
Esmolol—Headache—Temozolomide—skin cancer	0.00119	0.00119	CcSEcCtD
Esmolol—Hypotension—Docetaxel—skin cancer	0.00118	0.00118	CcSEcCtD
Esmolol—Dizziness—Fluorouracil—skin cancer	0.00116	0.00116	CcSEcCtD
Esmolol—Paraesthesia—Docetaxel—skin cancer	0.00113	0.00114	CcSEcCtD
Esmolol—Nausea—Temozolomide—skin cancer	0.00113	0.00113	CcSEcCtD
Esmolol—Dyspnoea—Docetaxel—skin cancer	0.00113	0.00113	CcSEcCtD
Esmolol—Somnolence—Docetaxel—skin cancer	0.00112	0.00112	CcSEcCtD
Esmolol—Vomiting—Fluorouracil—skin cancer	0.00111	0.00111	CcSEcCtD
Esmolol—Dyspepsia—Docetaxel—skin cancer	0.00111	0.00111	CcSEcCtD
Esmolol—Decreased appetite—Docetaxel—skin cancer	0.0011	0.0011	CcSEcCtD
Esmolol—Headache—Fluorouracil—skin cancer	0.0011	0.0011	CcSEcCtD
Esmolol—Gastrointestinal disorder—Docetaxel—skin cancer	0.00109	0.00109	CcSEcCtD
Esmolol—Fatigue—Docetaxel—skin cancer	0.00109	0.00109	CcSEcCtD
Esmolol—Constipation—Docetaxel—skin cancer	0.00108	0.00108	CcSEcCtD
Esmolol—Pain—Docetaxel—skin cancer	0.00108	0.00108	CcSEcCtD
Esmolol—Feeling abnormal—Docetaxel—skin cancer	0.00104	0.00104	CcSEcCtD
Esmolol—Nausea—Fluorouracil—skin cancer	0.00104	0.00104	CcSEcCtD
Esmolol—Body temperature increased—Docetaxel—skin cancer	0.000999	0.000999	CcSEcCtD
Esmolol—Asthenia—Docetaxel—skin cancer	0.000907	0.000907	CcSEcCtD
Esmolol—Pruritus—Docetaxel—skin cancer	0.000894	0.000894	CcSEcCtD
Esmolol—Dizziness—Docetaxel—skin cancer	0.000836	0.000836	CcSEcCtD
Esmolol—Vomiting—Docetaxel—skin cancer	0.000804	0.000804	CcSEcCtD
Esmolol—Headache—Docetaxel—skin cancer	0.000792	0.000792	CcSEcCtD
Esmolol—Nausea—Docetaxel—skin cancer	0.000751	0.000751	CcSEcCtD
Esmolol—Chlorphenesin—PTGS2—skin cancer	0.000227	0.691	CrCbGaD
Esmolol—Ibuprofen—PTGS2—skin cancer	0.000101	0.309	CrCbGaD
